<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01250158</url>
  </required_header>
  <id_info>
    <org_study_id>CIP 000369</org_study_id>
    <nct_id>NCT01250158</nct_id>
  </id_info>
  <brief_title>Liver-PILP First-in-Man</brief_title>
  <acronym>PILP FiM</acronym>
  <official_title>First In-vivo Trial of the Liver Percutaneous Isolated Localized Perfusion (PILP) Set for the Treatment of Liver Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Device Works NV SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Celerion</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cromsource</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical Device Works NV SA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the PILP-kit can be safely used, within
      specific performance parameters, to isolate and perfuse the liver with a chemotherapeutic
      drug for the treatment of patients with unresectable liver metastases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this Medical Device Study, is to demonstrate the feasibility of the liver
      PILP intervention.

      The liver PILP intervention will be considered feasible if the procedure is demonstrated to
      be safe and the liver PILP kit performs according to specifications.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To demonstrate the feasibility of the liver PILP intervention.</measure>
    <time_frame>During intervention and up to 30 days post intervention</time_frame>
    <description>The liver PILP intervention will be considered feasible if the intervention is demonstrated to be safe and the PILP kit performs according to specifications related to localization, flow rates and retrieval of devices.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Liver Metastases</condition>
  <arm_group>
    <arm_group_label>Liver-PILP kit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Liver-PILP kit</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Liver-PILP kit</intervention_name>
    <description>Device: Liver-PILP kit The Liver-PILP kit (three devices) is composed of percutaneous, disposable (single-use), catheter-based devices for targeted, isolated, organ specific (liver), drug delivery and perfusion with high dose drugs.
The Portal Vein Device (PVD): balloon catheter to occlude the portal vein and allow aspiration through a central lumen for portal veno-venous bypass.
The Hepatic Artery Device (HAD): balloon catheter to occlude arterial flow to the liver.
The Vena Cava Device (VCD): catheter based device to isolate and access hepatic outflow to vena cava by creating a closed chamber in vena cava at ostia of the hepatic veins while maintaining central vena cava blood flow from lower extremities to right atrium through reduced central lumen.</description>
    <arm_group_label>Liver-PILP kit</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects with ECOG (Eastern Cooperative Oncology Group) stages 0 or 1

          2. Unresectable metastatic disease predominant in the liver

        Exclusion Criteria:

          1. More than 60 % tumor involved liver tissue

          2. Abnormal vascular anatomy

          3. Severe atherosclerosis

          4. Dissection and/or thrombotic occlusion and/or aneurysm of the aorta, iliac or hepatic
             arteries

          5. Short suprahepatic vena cava segment (&lt; 1.5 cm)

          6. One or both jugular veins are occluded

          7. Other severe, concomitant diseases regarding the subject status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Van Cutsem, Prof MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Leuven, Catholic University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karen Geboes, Prof MD Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luc Defreyne, Prof MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Van den Eynde, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Louvain Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Van Cutsem, Prof MD PhD</last_name>
    <phone>+32 16 344218</phone>
    <email>Eric.VanCutsem@uz.kuleuven.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Louvain Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Van den Eynce, MD</last_name>
      <phone>+3227641902</phone>
      <email>Marc.VandenEynde@UCLouvain.be</email>
    </contact>
    <investigator>
      <last_name>Pierre Goffette, Prof MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Agnes Docquier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel Van Boven, Prof MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amine Matta, Prof MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey Pospiech, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaud Lhommel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Defreyne, Prof MD PhD</last_name>
      <phone>+3293322937</phone>
      <email>Luc.Defreyne@UGent.be</email>
    </contact>
    <contact_backup>
      <last_name>Karen Geboes, Prof MD PhD</last_name>
      <phone>+3293322374</phone>
      <email>Karen.Geboes@UZGent.be</email>
    </contact_backup>
    <investigator>
      <last_name>Elilsabeth Dhondt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Wouters, Prof MD Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Filip De Somer, Prof RN Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvie Rottey, Prof MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven, Catholic University</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Van Cutsem, Prof MD PhD</last_name>
      <phone>+32 16 344218</phone>
      <email>Eric.VanCutsem@uz.kuleuven.ac.be</email>
    </contact>
    <investigator>
      <last_name>Chris Verslype, Prof MD Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geert Maleux, Prof MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Van de Velde, Prof MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diethard Monbaliu, Prof MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Maleux G, Monbaliu D, Verslype C, Casteleyn C, Van De Velde M, Cornillie P, Hoogeveen Y, Van Cutsem E. Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model. Eur Radiol. 2010 Oct;20(10):2372-80. doi: 10.1007/s00330-010-1816-5. Epub 2010 May 22.</citation>
    <PMID>20495978</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2010</study_first_submitted>
  <study_first_submitted_qc>November 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2010</study_first_posted>
  <last_update_submitted>March 28, 2013</last_update_submitted>
  <last_update_submitted_qc>March 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liver Percutaneous Isolated Localized Perfusion</keyword>
  <keyword>PILP</keyword>
  <keyword>Isolated Hepatic Perfusion</keyword>
  <keyword>IHP</keyword>
  <keyword>Liver metastases</keyword>
  <keyword>Unresectable liver metastases of different etiologies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

